ACC scientific statement reviewing evidence on direct oral anticoagulants (DOACs) for primary and secondary prevention of thrombotic events, covering AF, venous thromboembolism, special populations, periprocedural use, dosing, bleeding management and underuse.
Guideline
Kumbhani et al. Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events: 2026 ACC Scientific Statement: A Report of the American College of Cardiology